Auteur: acs

ADVERSE EVENT REPORTING UNDER MDR – EASY?

Under MDR Adverse Event reporting is meant to be more straightforward and uniform accross the different EU memberstates, but is that truely the case? One of the topics as discussed during the medical device joined ClinOps and RegNed springmeeting of the NVFG April 2023. Below you find the concerning presentation. Feel free to reach out […]

Lees meer

THE SHOCKING DATA ON CORONA ANTIGEN AND SELF-TESTS IN PRACTICE – PART 3

What causes misses in self tests of 50% or even more? What do we know based on data from clinical practice? In part 1, I showed that the tests can have a miss rate of 1 out of 3 to 1 out of 4 when professionals use it, and even a miss rate of 1 […]

Lees meer

THE SHOCKING DATA ON CORONA ANTIGEN AND SELF-TESTS IN PRACTICE – PART 2

The miss rates of corona self-tests as reported in practice are quite shocking compared those reported in the self-test labelling. What causes those misses? What do we know based on data from clinical practice? In part 1, I showed that the tests can have a miss rate of 1 out of 3 to 1 out […]

Lees meer

THE SHOCKING DATA ON CORONA ANTIGEN AND SELF-TESTS IN PRACTICE – PART 1

The miss rates of corona antigen self-tests as reported in practice are quite shocking compared those reported in the self-test labelling. What causes those misses? What do we know based on data from clinical practice? I looked at 6 reasons (and a bonus reason) that may explain why self-tests miss a diagnosis, and checked the […]

Lees meer

THE MDR IS THERE: BE AWARE OF THE LATEST ISO14155!

With the updated references of harmonised standards for medical devices, ISO 14155: 2020 is THE GCP standard for medical device clinical investigations, and since as of May 26th 2021 the MDR fully applies you may want to familiarize yourself and your team with the changes to ensure proper clinical data collection in line with this […]

Lees meer

EU Guidelines on COVID-19 and clinical trials

  CCMO News item: Conditions for (re)starting clinical research in healthcare institutions and CRUs aligned —– NEN publishes new recommendations for reusing single-use medical devices and provides guidance for non-medical face masks (Dutch) NEN quality mark for masks for public use ready as per December 15, 2020 —- The European Data Protection Board (EDPD) adopted guidelines […]

Lees meer

Brexit: MHRA new rules for January 2021 |

MHRA post-transition period information: Guidances for industry and organisations to follow from 1 January 2021. Last updated on December 11, 2020.

Lees meer

FAQs on the UDI system |

A European Commission’s document with frequently asked questions on the Unique Device Identification (UDI) System under the EU medical devices Regulations 2017/745 and 2017/746.

Lees meer

ISO 14155:2020 Clinical investigation of medical devices – Good clinical practice

https://www.iso.org/standard/71690.html

Lees meer

CCMO on Brexit and clinical research

Brexit and clinical research The United Kingdom (UK) has left the European Union (EU) on 31 January 2020. A transitional period is now in place until 31 December 2020. During this period, all EU laws and regulations will continue to apply in the UK. Virtually nothing will change for the public and for businesses during […]

Lees meer